TrialFrontiers in immunology2021

Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study.

Jun Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.